Jeanne Cunicelli, a veteran venture capitalist in the life sciences industry, became president of UPMC Enterprises in January 2021. Jeanne was a managing director at Bay City Capital in San Francisco before joining UPMC in 2017 to lead UPMC Enterprises’ Translational Sciences focus area.
As president of UPMC Enterprises, Jeanne is leading UPMC’s efforts to commercialize its managerial and health care expertise. With a focus on improving the quality, efficiency and patient experience at UPMC, the division and its partners will then take those solutions to the broader health care market through its two focus areas, Translational Sciences and Digital Solutions.
Under Jeanne’s leadership, the Translational Sciences team has grown to more than 20 scientific and investment professionals working to accelerate the transfer of scientific discoveries into life-changing medicines, diagnostics and devices. Based on ground-breaking research from the University of Pittsburgh and other global innovators, the team will deploy $1 billion in life sciences investments by 2024. Through its Digital Solutions group, UPMC Enterprises has started and invested in a portfolio of companies that leverages UPMC’s scale and health care insights to provide clinicians, payers and consumers with engaging technology that improves the quality and cost effectiveness of health care.
Jeanne is a member of the Board of Trustees of Carnegie Mellon University. She received an M.B.A. from the University of San Francisco and a bachelor’s degree in cognitive psychology from Carnegie Mellon University.